These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 16619478
1. JAS-R, a new megakaryo-erythroid leukemic cell line that secretes erythropoietin. Sekikawa T, Iwase S, Saito S, Arakawa Y, Agawa M, Horiguchi-Yamada J, Yamada H. Anticancer Res; 2006; 26(2A):843-50. PubMed ID: 16619478 [Abstract] [Full Text] [Related]
2. Segregation of megakaryocytic or erythroid cells from a megakaryocytic leukemia cell line (JAS-R) by adhesion during culture. Yamada H, Sekikawa T, Iwase S, Arakawa Y, Suzuki H, Agawa M, Akiyama M, Takeda N, Horiguchi-Yamada J. Leuk Res; 2007 Nov; 31(11):1537-43. PubMed ID: 17383723 [Abstract] [Full Text] [Related]
3. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles. Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K. Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248 [Abstract] [Full Text] [Related]
4. Establishment and characterization of a new human erythroleukemic cell line, ERY-1. Ribadeau Dumas A, Hamouda NB, Leriche L, Piffaut MC, Bonnemye P, Kuen RL, Tricottet V, Merle-Beral H, N'Guyen Khac F, Arock M. Leuk Res; 2004 Dec; 28(12):1329-39. PubMed ID: 15475075 [Abstract] [Full Text] [Related]
5. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia. Drexler HG, Matsuo Y, MacLeod RA. Leuk Res; 2004 Dec; 28(12):1243-51. PubMed ID: 15475063 [Abstract] [Full Text] [Related]
6. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5). Adachi M, Ryo R, Sato T, Yamaguchi N. Exp Hematol; 1991 Oct; 19(9):923-7. PubMed ID: 1893970 [Abstract] [Full Text] [Related]
7. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia]. Ryo R, Yoshida A, Yamaguchi N. Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077 [Abstract] [Full Text] [Related]
8. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. Takeuchi S, Sugito S, Uemura Y, Miyagi T, Kubonishi I, Taguchi H, Enzan H, Ohtsuki Y, Miyoshi I. Leukemia; 1992 Jun; 6(6):588-94. PubMed ID: 1602796 [Abstract] [Full Text] [Related]
9. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Elmaagacli AH, Koldehoff M, Zakrzewski JL, Steckel NK, Ottinger H, Beelen DW. Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408 [Abstract] [Full Text] [Related]
10. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis. Tange T, Nakahara K, Mitani K, Yamasaki I, Yasuda H, Tanaka F, Mizuguchi M, Oda H, Yatomi Y, Takanashi R. Cancer Res; 1988 Nov 01; 48(21):6137-44. PubMed ID: 3167860 [Abstract] [Full Text] [Related]
11. [Infant leukemia with t(1;22) presenting proliferation of erythroid and megakaryocytic cell lineages]. Oshima M, Fukushima T, Koike K, Hoshida C, Izumi I, Tsuchida M. Rinsho Ketsueki; 1999 Mar 01; 40(3):230-5. PubMed ID: 10222631 [Abstract] [Full Text] [Related]
12. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia. Maitta RW, Wolgast LR, Wang Q, Zhang H, Bhattacharyya P, Gong JZ, Sunkara J, Albanese JM, Pizzolo JG, Cannizzaro LA, Ramesh KH, Ratech H. Am J Hematol; 2011 Feb 01; 86(2):230-4. PubMed ID: 21264917 [Abstract] [Full Text] [Related]
13. Acute myeloid leukemia cell lines MOLM-17 and MOLM-18 derived from patient with advanced myelodysplastic syndromes. Matsuo Y, Drexler HG, Harashima A, Okochi A, Kojima K, Asakura S, Tanimoto M, Orita K. Leuk Res; 2005 Jun 01; 29(6):701-10. PubMed ID: 15863212 [Abstract] [Full Text] [Related]
14. [Establishment and biological characteristics of a novel erythroleukemia cell line (HIE1)]. Han J, Han M, Liu S, Li C, Zhou Z, Li X, Yan H, Cui W, Liu J, Mi Y. Zhonghua Xue Ye Xue Za Zhi; 2000 Jan 01; 21(1):6-9. PubMed ID: 11876951 [Abstract] [Full Text] [Related]
15. Establishment and characterization of a new erythroblastic leukemia cell line, EEB: phosphatidylglucoside-mediated erythroid differentiation and apoptosis. Kawano-Yamamoto C, Muroi K, Nagatsuka Y, Higuchi M, Kikuchi S, Nagai T, Hakomori SI, Ozawa K. Leuk Res; 2006 Jul 01; 30(7):829-39. PubMed ID: 16332389 [Abstract] [Full Text] [Related]
16. Megakaryoblastic leukemia cell line MOLM-16 derived from minimally differentiated acute leukemia with myeloid/NK precursor phenotype. Matsuo Y, Drexler HG, Kaneda K, Kojima K, Ohtsuki Y, Hara M, Yasukawa M, Tanimoto M, Orita K. Leuk Res; 2003 Feb 01; 27(2):165-71. PubMed ID: 12526922 [Abstract] [Full Text] [Related]
17. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation. Buck I, Morceau F, Cristofanon S, Heintz C, Chateauvieux S, Reuter S, Dicato M, Diederich M. Biochem Pharmacol; 2008 Nov 15; 76(10):1229-39. PubMed ID: 18805401 [Abstract] [Full Text] [Related]
18. The alpha1-adrenergic receptor antagonists, benoxathian and prazosin, induce apoptosis and a switch towards megakaryocytic differentiation in human erythroleukemia cells. Fuchs R, Stelzer I, Haas HS, Leitinger G, Schauenstein K, Sadjak A. Ann Hematol; 2009 Oct 15; 88(10):989-97. PubMed ID: 19241077 [Abstract] [Full Text] [Related]
19. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Morita S, Tsuchiya S, Fujie H, Itano M, Ohashi Y, Minegishi M, Imaizumi M, Endo M, Takano N, Konno T. Leukemia; 1996 Jan 15; 10(1):102-5. PubMed ID: 8558913 [Abstract] [Full Text] [Related]
20. Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration. Qiu H, Xue Y, Zhang J, Pan J, Dai H, Wu Y, Wang Y, Chen S, Wu D. Exp Hematol; 2008 Nov 15; 36(11):1487-95. PubMed ID: 18715689 [Abstract] [Full Text] [Related] Page: [Next] [New Search]